Normalizing Timing News Today

In 2021, a Northwestern University-led research team received a Defense Advanced Research Projects Agency (DARPA) contract worth up to $33 million to develop an implantable "living pharmacy" to control the human body's sleep/wake cycles.

<p>Researchers have developed a novel device that produces oxygen inside of a "living pharmacy" implant in order to keep cells alive inside the self-contained device. The device produses oxygen through a smart, energy-efficient version of water splitting. In new experiments, the novel device kept cells (70-80%) alive for close to a month in low oxygen conditions in vitro, or weeks in vivo. Without ecO<sub>2</sub>, only about 20% of c...

It involves using an implant in the brain. When Blackrock co-founders Marcus Gerhardt and Florian Solzbacher were teenagers, they attended a private preparatory boarding school together in repurposed military housing in a castle near the ocean in Wales. One day teenage Gerhardt told teenage Solzbacher that he had no idea what he wanted to do with his life. Solzbacher responded with singular purpose that he knew exactly what he wanted to do. "I want to create the connection between artificial an...

July 6, 2021 By Deborah Borfitz July 6, 2021 | A trio of universities are putting their heads together to engineer a wirelessly controlled bioelectronic implant intended to help soldiers adapt to new time zones or drastic changes in their work schedules by releasing peptide-based therapies to harmonize their central and peripheral circadian clocks. The solicitation came from the Defense Advanced Research Projects Agency (DARPA) and the timeline is ambitious, with a first-in-human s...

Implantable living pharmacy will halve jet lag recovery time Ian Randall For Mailonline © Provided by Daily Mail MailOnline logo An implantable living pharmacy that may be able to halve the time it takes to recover from jet lag is being developed by researchers from Illinois. Northwestern University experts have signed a $33 million (£23.3 million) contract with the US Defense Advanced Research Projects Agency to develop the device. Combining synthetic biology with electron...

The implant is being developed by a team led from Northwestern University It will contain engineered cells that produce peptides when stimulated by light These same peptides are used within the body to regulate sleep/wake cycles  Triggered wirelessly, the device could release precise doses to combat jet lag  US military agency DARPA is funding the project to the tune of $33 million Beyond travellers, other potential users could include workers on varying shifts 

Nanotechnology Now Our NanoNews Digest Sponsors Home > Press > Implantable living pharmacy could control bodys sleep/wake cycles: Project receives DARPA contract worth up to $33 million over 4 1/2 years In this artistic illustration, a user with an NTRAIN implant and its accompanying external hub works in the field. The user inputs a desired time shift (due to shift work or travel across time zones). Based on cues from the body’s physiology, the external hub detects the user’s circadian rhyth...

Scientists are designing an implant to control the bodys circadian clock It would contain engineered cells that produce the same peptides the body makes to regulate sleep cycles Users can adjust the device to a specific shift, in which a beam of light would zap the cells to release peptides when it is time for the user to fall asleep The device is aimed to be used by military personnel and first responders 

  Blackrock Microsystems, a privately held company that provides enabling tools for neuroscience, neural engineering and neuroprosthetics research worldwide partnered with a team of interdisciplinary researchers at Northwestern University, who signed a contract with the Defense Advanced Research Projects Agency (DARPA) to develop a wireless, fully implantable device that can shift the bodys circadian clock, halving the time it takes to recover from disrupted sleep/wake cycles. The device power...